NCT00616317 Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
| NCT ID | NCT00616317 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Davis |
| Condition | Antiphospholipid Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2006-09 |
| Primary Completion | 2040-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2006-09 with a primary completion date of 2040-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or younger at the onset of disease * Presence of Vascular Thrombosis * UC Davis patient * Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma Exclusion Criteria: * Infants born to mothers with APS * Infants with congenital thrombophilia
Contact & Investigator
Lavjay Butani
📞 (916) 734-8118
Lavjay Butani, M.D.
PRINCIPAL INVESTIGATOR
University of California, Davis
Frequently Asked Questions
Who can join the NCT00616317 clinical trial?
This trial is open to participants of all sexes, aged 1 Minute or older, up to 18 Years, studying Antiphospholipid Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00616317 currently recruiting?
Yes, NCT00616317 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of California, Davis to inquire about joining.
Where is the NCT00616317 trial being conducted?
This trial is being conducted at Sacramento, United States.
Who is sponsoring the NCT00616317 clinical trial?
NCT00616317 is sponsored by University of California, Davis. The principal investigator is Lavjay Butani, M.D. at University of California, Davis. The trial plans to enroll 50 participants.